Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:401-411
doi: 10.1161/01.RES.0000158287.49872.4e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riddle, E. L.
Right arrow Articles by Insel, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riddle, E. L.
Right arrow Articles by Insel, P. A.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Cell signalling/signal transduction
Right arrow Heart failure - basic studies
Right arrow Hypertension - basic studies
Right arrow Receptor pharmacology
(Circulation Research. 2005;96:401.)
© 2005 American Heart Association, Inc.


Review

Multi-Tasking RGS Proteins in the Heart

The Next Therapeutic Target?

Evan L. Riddle, Raúl A. Schwartzman, Meredith Bond, Paul A. Insel

From the Department of Pharmacology (E.L.R., P.A.I.), University of California San Diego, La Jolla; the Department of Physiology (R.A.S., M.B.), University of Maryland School of Medicine, Baltimore; and the Department of Molecular Cardiology (M.B.), Lerner Research Institute, The Cleveland Clinic Foundation, Ohio.

Correspondence to Meredith Bond, PhD, Department of Physiology, University of Maryland, 655 W Baltimore St, Baltimore, MD 21201. E-mail mbond001{at}umaryland.edu

This Review is part of a thematic series on Heterodimerization of Signaling Molecules, which includes the following articles:

Regulation of G Protein–Coupled Receptor Signaling By Scaffold Proteins

G Protein–Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling

Multi-Tasking RGS Proteins in the Heart: The Next Therapeutic Target?
Gerda Breitwieser Editor

Regulator of G-protein–signaling (RGS) proteins play a key role in the regulation of G-protein–coupled receptor (GPCR) signaling. The characteristic hallmark of RGS proteins is a conserved {approx}120-aa RGS region that confers on these proteins the ability to serve as GTPase-activating proteins (GAPs) for G{alpha} proteins. Most RGS proteins can serve as GAPs for multiple isoforms of G{alpha} and therefore have the potential to influence many cellular signaling pathways. However, RGS proteins can be highly regulated and can demonstrate extreme specificity for a particular signaling pathway. RGS proteins can be regulated by altering their GAP activity or subcellular localization; such regulation is achieved by phosphorylation, palmitoylation, and interaction with protein and lipid-binding partners. Many RGS proteins have GAP-independent functions that influence GPCR and non-GPCR–mediated signaling, such as effector regulation or action as an effector. Hence, RGS proteins should be considered multifunctional signaling regulators. GPCR-mediated signaling is critical for normal function in the cardiovascular system and is currently the primary target for the pharmacological treatment of disease. Alterations in RGS protein levels, in particular RGS2 and RGS4, produce cardiovascular phenotypes. Thus, because of the importance of GPCR-signaling pathways and the profound influence of RGS proteins on these pathways, RGS proteins are regulators of cardiovascular physiology and potentially novel drug targets as well.


Key Words: RGS protein • regulator of G-protein signaling • GPCRheart




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. M. Tuomi, P. Chidiac, and D. L. Jones
Evidence for enhanced M3 muscarinic receptor function and sensitivity to atrial arrhythmia in the RGS2-deficient mouse
Am J Physiol Heart Circ Physiol, February 1, 2010; 298(2): H554 - H561.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. K. K. Pacey, S. P. Heximer, and D. R. Hampson
Increased GABAB Receptor-Mediated Signaling Reduces the Susceptibility of Fragile X Knockout Mice to Audiogenic Seizures
Mol. Pharmacol., July 1, 2009; 76(1): 18 - 24.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Hu, F. Li, S. Mahavadi, and K. S. Murthy
Upregulation of RGS4 expression by IL-1{beta} in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3{beta} pathway
Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1310 - C1320.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
M. Lelonek, T. Pietrucha, M. Matyjaszczyk, and J. H. Goch
A novel approach to syncopal patients: association analysis of polymorphisms in G-protein genes and tilt outcome
Europace, January 1, 2009; 11(1): 89 - 93.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Iankova, C. Chavey, C. Clape, C. Colomer, N. C. Guerineau, N. Grillet, J.-F. Brunet, J.-S. Annicotte, and L. Fajas
Regulator of G Protein Signaling-4 Controls Fatty Acid and Glucose Homeostasis
Endocrinology, November 1, 2008; 149(11): 5706 - 5712.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Tokudome, I. Kishimoto, T. Horio, Y. Arai, D. O. Schwenke, J. Hino, I. Okano, Y. Kawano, M. Kohno, M. Miyazato, et al.
Regulator of G-Protein Signaling Subtype 4 Mediates Antihypertrophic Effect of Locally Secreted Natriuretic Peptides in the Heart
Circulation, May 6, 2008; 117(18): 2329 - 2339.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
K. V. Chowdari, M. Bamne, J. Wood, M. E. Talkowski, K. Mirnics, P. Levitt, D. A. Lewis, and V. L. Nimgaonkar
Linkage Disequilibrium Patterns and Functional Analysis of RGS4 Polymorphisms in Relation to Schizophrenia
Schizophr Bull, January 1, 2008; 34(1): 118 - 126.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Huang, R. A. Charbeneau, Y. Fu, K. Kaur, I. Gerin, O. A. MacDougald, and R. R. Neubig
Resistance to Diet-Induced Obesity and Improved Insulin Sensitivity in Mice With a Regulator of G Protein Signaling Insensitive G184S Gnai2 Allele
Diabetes, January 1, 2008; 57(1): 77 - 85.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Makita, J. Sato, P. Rondard, H. Fukamachi, Y. Yuasa, M. A. Aldred, M. Hashimoto, T. Fujita, and T. Iiri
Human Gs{alpha} mutant causes pseudohypoparathyroidism type Ia/neonatal diarrhea, a potential cell-specific role of the palmitoylation cycle
PNAS, October 30, 2007; 104(44): 17424 - 17429.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
D. G Romero, M. Y. Zhou, L. L Yanes, M. W Plonczynski, T. R Washington, C. E Gomez-Sanchez, and E. P Gomez-Sanchez
Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion
J. Endocrinol., August 1, 2007; 194(2): 429 - 440.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Engelhardt and F. Rochais
G Proteins: More Than Transducers of Receptor-Generated Signals?
Circ. Res., April 27, 2007; 100(8): 1109 - 1111.
[Full Text] [PDF]


Home page
EndocrinologyHome page
G. Fejes-Toth and A. Naray-Fejes-Toth
Early Aldosterone-Regulated Genes in Cardiomyocytes: Clues to Cardiac Remodeling?
Endocrinology, April 1, 2007; 148(4): 1502 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. L. Roman, J. N. Talbot, R. A. Roof, R. K. Sunahara, J. R. Traynor, and R. R. Neubig
Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay
Mol. Pharmacol., January 1, 2007; 71(1): 169 - 175.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Wang and H. G. Dohlman
Regulation of G Protein and Mitogen-Activated Protein Kinase Signaling by Ubiquitination: Insights From Model Organisms
Circ. Res., December 8, 2006; 99(12): 1305 - 1314.
[Abstract] [Full Text] [PDF]


Home page
Schizophr BullHome page
M. E Talkowski, K. Chowdari, D. A Lewis, and V. L Nimgaonkar
Can RGS4 Polymorphisms Be Viewed as Credible Risk Factors for Schizophrenia? A Critical Review of the Evidence
Schizophr Bull, April 1, 2006; 32(2): 203 - 208.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Wieland and S. Herzig
Specificity and Diversity in Gi/o-Mediated Signaling: How the Heart Operates the RGS Brake Pedal
Circ. Res., March 17, 2006; 98(5): 585 - 586.
[Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Fu, X. Huang, H. Zhong, R. M. Mortensen, L. G. D'Alecy, and R. R. Neubig
Endogenous RGS Proteins and G{alpha} Subtypes Differentially Control Muscarinic and Adenosine-Mediated Chronotropic Effects
Circ. Res., March 17, 2006; 98(5): 659 - 666.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zhang, T. Anger, J. Su, J. Hao, X. Xu, M. Zhu, A. Gach, L. Cui, R. Liao, and U. Mende
Selective Loss of Fine Tuning of Gq/11 Signaling by RGS2 Protein Exacerbates Cardiomyocyte Hypertrophy
J. Biol. Chem., March 3, 2006; 281(9): 5811 - 5820.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. L. Riddle, B. K. Rana, K. K. Murthy, F. Rao, E. Eskin, D. T. O'Connor, and P. A. Insel
Polymorphisms and Haplotypes of the Regulator of G Protein Signaling-2 Gene in Normotensives and Hypertensives
Hypertension, March 1, 2006; 47(3): 415 - 420.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. J. Ward and G. Milligan
A Key Serine for the GTPase-Activating Protein Function of Regulator of G Protein Signaling Proteins Is Not a General Target for 14-3-3 Interactions
Mol. Pharmacol., December 1, 2005; 68(6): 1821 - 1830.
[Abstract] [Full Text] [PDF]